IFIH1 and dermatomyositis: The results demonstrated that a significant relationship was found between anti-MDA5 antibody and ILD or RPILD in DM patients, indicating that anti-MDA5 antibody has potential value as a noninvasive biomarker for DM-ILD and DM-RPILD.